Extending the time window for stroke treatment: advanced brain imaging ± bat saliva

被引:4
作者
De Georgia, Michael [1 ,2 ,3 ]
机构
[1] Univ Hosp Cleveland, Neurocrit Care Ctr, Case Med Ctr, Cleveland, OH 44106 USA
[2] Univ Hosp Cleveland, Cerebrovasc Ctr, Case Med Ctr, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
关键词
ischemia; MRI; stroke; thrombolysis; tissue plasminogen activator; ACUTE ISCHEMIC-STROKE; PLASMINOGEN-ACTIVATOR DESMOTEPLASE; THROMBOLYSIS; MRI; DIFFUSION; ONSET;
D O I
10.1111/j.1747-4949.2009.00257.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:94 / 96
页数:3
相关论文
共 13 条
[1]   Breaking the 3 h barrier for treatment of acute ischaemic stroke [J].
Donnan, Geoffrey A. ;
Davis, Stephen M. .
LANCET NEUROLOGY, 2008, 7 (11) :981-982
[2]   Dose escalation of desmoteplase for acute ischemic stroke (DEDAS) - Evidence of safety and efficacy 3 to 9 hours after stroke onset [J].
Furlan, AJ ;
Eyding, D ;
Albers, GW ;
Al-Rawi, Y ;
Lees, KR ;
Rowley, HA ;
Sachara, C ;
Soehngen, M ;
Warach, S ;
Hacke, W .
STROKE, 2006, 37 (05) :1227-1231
[3]   The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase [J].
Hacke, W ;
Albers, G ;
Al-Rawi, Y ;
Bogousslavsky, J ;
Davalos, A ;
Eliasziw, M ;
Fischer, M ;
Furlan, A ;
Kaste, M ;
Lees, KR ;
Soehngen, M ;
Warach, S .
STROKE, 2005, 36 (01) :66-73
[4]   MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset:: a cohort study [J].
Koehrmann, Martin ;
Juettler, Eric ;
Fiebach, Jochen B. ;
Huttner, Hagen B. ;
Siebert, Stefan ;
Schwark, Christian ;
Ringleb, Peter A. ;
Schellinger, Peter D. ;
Hacke, Werner .
LANCET NEUROLOGY, 2006, 5 (08) :661-667
[5]   Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE [J].
Lansberg, Maarten G. ;
Thijs, Vincent N. ;
Hamilton, Scott ;
Schlaug, Gottfried ;
Bammer, Roland ;
Kemp, Stephanie ;
Albers, Gregory W. .
STROKE, 2007, 38 (06) :1826-1830
[6]   Vampire bat salivary plasminogen activator (desmoteplase) - A unique fibrinolytic enzyme that does not promote neurodegeneration [J].
Liberatore, GT ;
Samson, A ;
Bladin, C ;
Schleuning, WD ;
Medcalf, RL .
STROKE, 2003, 34 (02) :537-543
[7]   TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587
[8]   The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling [J].
Nicole, O ;
Docagne, F ;
Ali, C ;
Margaill, I ;
Carmeliet, P ;
MacKenzie, ET ;
Vivien, D ;
Buisson, A .
NATURE MEDICINE, 2001, 7 (01) :59-64
[9]   Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke [J].
Parsons, MW ;
Barber, PA ;
Chalk, J ;
Darby, DG ;
Rose, S ;
Desmond, PM ;
Gerraty, RP ;
Tress, BM ;
Wright, PM ;
Donnan, GA ;
Davis, SM .
ANNALS OF NEUROLOGY, 2002, 51 (01) :28-37
[10]   Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury [J].
Reddrop, C ;
Moldrich, RX ;
Beart, PM ;
Farso, M ;
Liberatore, GT ;
Howells, DW ;
Petersen, KU ;
Schleuning, WD ;
Medcalf, RL .
STROKE, 2005, 36 (06) :1241-1246